This page shows the latest Merial news and features for those working in and with pharma, biotech and healthcare.
2016 was a disruptive year for Boehringer Ingelheim, punctuated by the sale of its consumer health and US generics business and the absorption of Sanofi's animal health unit Merial, which
Valued at a combined total of 21.8bn, the transaction saw Sanofi exchange its animal health business, Merial, for Boehringer's consumer healthcare business, CHC. ... However, the deal isn't entirely finished. The firms are still waiting for regulatory
The companies must now wait for the animal health part of their swap, which will see Sanofi's Merial business acquired by Boehringer, to be approved.
The company has already sold its US generics business Roxane Labs, and in June signed a contract to swap Sanofi's animal health business Merial with its consumer health care business -
Will exchange Merial animal health business for consumer healthcare unit in $25bn deal. ... Sanofi will transfer ownership of the 11.4bn Merial division to Boehringer in return for the latter's consumer health unit - valued at 6.7bn - and 4.7bn in cash.
Meanwhile, Carsten Hellmann, executive vice president of Sanofi's animal health company Merial, is set to move to ALK as president and CEO, but has agreed to stay on until
More from news
Approximately 2 fully matching, plus 26 partially matching documents found.
animal health business (Merial) for Boehringer Ingelheim's consumer healthcare business.
In June, Boehringer Ingelheim agreed to takeover Sanofi's veterinary business, Merial, in return for handing over its OTC business. ... pet vaccines business and Fort Dodge manufacturing site is a required step toward the acquisition of Merial by
The latter deal will see Boehringer hand its consumer health interests to Sanofi in return for the French pharma firm's animal health arm Merial.
As the enterprise value of Sanofi's animal business, Merial, was estimated at 11.4bn versus 6.7bn for Boehringer's consumer health business, Boehringer is required to pay 4.7bn (
In a similar move to expand global presence, Sanofi's animal health company, Merial, has acquired the Indian veterinary business Dosch for an undisclosed amount.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Carsten Hellmann (pictured left) joins Sanofi from food ingredient company Chr Hansen and takes over from Jose Barella as executive VP for Sanofi's animal health division Merial. ... He now takes control of a company with annual revenues of more than 2bn,
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...